Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mannkind Corp (MNKD)

Mannkind Corp (MNKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,587,781
  • Shares Outstanding, K 303,591
  • Annual Sales, $ 285,500 K
  • Annual Income, $ 27,590 K
  • EBIT $ 73 M
  • EBITDA $ 83 M
  • 60-Month Beta 1.27
  • Price/Sales 5.55
  • Price/Cash Flow 37.61
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 101.23% ( -40.20%)
  • Historical Volatility 32.95%
  • IV Percentile 72%
  • IV Rank 41.83%
  • IV High 229.09% on 04/30/24
  • IV Low 9.30% on 10/22/24
  • Put/Call Vol Ratio 0.10
  • Today's Volume 185
  • Volume Avg (30-Day) 1,441
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 48,581
  • Open Int (30-Day) 49,690

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.03
  • Number of Estimates 1
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.77 +9.43%
on 03/10/25
5.74 -9.06%
on 02/27/25
-0.43 (-7.61%)
since 02/25/25
3-Month
4.77 +9.43%
on 03/10/25
6.90 -24.35%
on 12/26/24
-1.52 (-22.55%)
since 12/24/24
52-Week
3.97 +31.49%
on 04/17/24
7.63 -31.59%
on 11/06/24
+0.32 (+6.53%)
since 03/25/24

Most Recent Stories

More News
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

MNKD : 5.22 (-0.19%)
MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’

The company significantly reduced its debt principal by $236 million, leaving just $36 million in remaining convertible debt, and ended 2024 with $203 million in cash, cash equivalents, and investments....

VXF : 181.08 (-0.57%)
MNKD : 5.22 (-0.19%)
XBI : 87.08 (-1.96%)
IWM : 207.70 (-0.56%)
MannKind (MNKD) Q4 2024 Earnings Call Transcript

MNKD earnings call for the period ending December 31, 2024.

MNKD : 5.22 (-0.19%)
MannKind: Q4 Earnings Snapshot

MannKind: Q4 Earnings Snapshot

MNKD : 5.22 (-0.19%)
MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

MNKD : 5.22 (-0.19%)
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025

MNKD : 5.22 (-0.19%)
MannKind to Present at Upcoming Investor Conferences

MNKD : 5.22 (-0.19%)
MannKind Expands Executive Leadership Team

MNKD : 5.22 (-0.19%)
MannKind Corporation Reduces Debt by $194 Million and Strengthens Cash Position to Over $180 Million

MannKind Corporation reduces debt by $194 million and increases cash position to over $180 million through note exchanges.Quiver AI SummaryMannKind Corporation has announced a significant reduction in...

MNKD : 5.22 (-0.19%)
MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash

MNKD : 5.22 (-0.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder...

See More

Key Turning Points

3rd Resistance Point 5.38
2nd Resistance Point 5.32
1st Resistance Point 5.27
Last Price 5.22
1st Support Level 5.16
2nd Support Level 5.10
3rd Support Level 5.05

See More

52-Week High 7.63
Fibonacci 61.8% 6.23
Fibonacci 50% 5.80
Fibonacci 38.2% 5.37
Last Price 5.22
52-Week Low 3.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar